MedPath

The Effects of Body Mass Index on Erector Spinae Plane Block Analgesia

Not Applicable
Completed
Conditions
Pain Postoperative
Lumbar Disc Herniation
Erector Spinae Plane Block
Body Mass Index
Pain
Pain Acute
Interventions
Procedure: Erector spinae plane block
Registration Number
NCT06257953
Lead Sponsor
Atatürk Chest Diseases and Chest Surgery Training and Research Hospital
Brief Summary

In recent years, obesity has become one of the leading health problems worldwide. It is known that obesity can cause various diseases and negatively impact the quality of life. Therefore, many conditions believed to be affected by obesity and relevant to patients\' quality of life have been scientifically investigated and continue to be researched. One of these conditions is postoperative pain, with studies in the literature indicating that postoperative pain levels increase in parallel with each unit increase in BMI.

The incidence of lumbar disc herniation (LDH) is on the rise and adversely affecting the quality of life. The primary surgical intervention for LDH is discectomy. In recent years, various less invasive techniques, such as microdiscectomy, have been described to improve both surgical and analgesic outcomes. However, even with microdiscectomy surgery, postoperative pain may occur, and its control should be well-managed. Inadequate pain control can lead to unwanted effects of postoperative pain. Regional analgesia techniques may be preferred for effective analgesic treatment after spinal surgery. Methods such as paravertebral block, erector spinae plane block (ESPB), thoracolumbar interfascial plane block are widely used for analgesia in spinal surgery. The effectiveness of these regional techniques may vary depending on various factors, one of which is BMI.

The hypothesis in this study is that as BMI increases, the level of pain in patients may also increase. As a result, this study aims to investigate the relationship between BMI and postoperative pain levels in patients undergoing standard LDH surgery, anesthesia, and analgesia.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
75
Inclusion Criteria
  • 18 to 65 years old
  • ASA physical status I-II-III
  • BMI 18 to 40 kg/m2
  • Elective LDH surgery
Exclusion Criteria
  • Patient refusing the procedure
  • Patients who have previously undergone spinal surgery
  • Chronic opioid or analgesic use
  • Patients who will operate under emergency conditions
  • Patients who will not undergo LDH surgery

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Patients with a BMI of 25-29.9 kg/m2Erector spinae plane blockFollowing the visualization of the anatomical structures, the nerve block needle was advanced via the in-plane technique beneath the erector spinae muscles until the interfascial space was reached. After hydrodissection with 2 ml normal saline, 15 ml of 0.25% bupivacaine was injected into the area. Then the block process will be applied to the other side in the same way. A total of 30 ml of 15 ml 0.25% bupivacaine will be injected.
Patients with a BMI of 18-24.9 kg/m2Erector spinae plane blockFollowing the visualization of the anatomical structures, the nerve block needle was advanced via the in-plane technique beneath the erector spinae muscles until the interfascial space was reached. After hydrodissection with 2 ml normal saline, 15 ml of 0.25% bupivacaine was injected into the area. Then the block process will be applied to the other side in the same way. A total of 30 ml of 15 ml 0.25% bupivacaine will be injected.
Patients with a BMI of 30-40 kg/m2Erector spinae plane blockFollowing the visualization of the anatomical structures, the nerve block needle was advanced via the in-plane technique beneath the erector spinae muscles until the interfascial space was reached. After hydrodissection with 2 ml normal saline, 15 ml of 0.25% bupivacaine was injected into the area. Then the block process will be applied to the other side in the same way. A total of 30 ml of 15 ml 0.25% bupivacaine will be injected.
Primary Outcome Measures
NameTimeMethod
Intraoperative remifentanil consumptionDuring the intraoperative period

The amount of remifentanil that patients need to maintain anesthesia during the intraoperative period will be recorded.

Secondary Outcome Measures
NameTimeMethod
Pain Scores24th hour after surgery.

Pain will be assessed at the 24th-hour rest and while coughing using the visual analog scale on a scale from 0 (no pain) to 10 (worst pain).

Trial Locations

Locations (1)

Ankara Etlik City Hospital

🇹🇷

Yenimahalle, Ankara, Turkey

© Copyright 2025. All Rights Reserved by MedPath